Wednesday, November 25, 2009, 12:50am SGT - The Singapore stock market opens in 8 hours and 10 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Cambrex Corp. (CBM)

At 12:32AM SGT: 5.80 USD  Down 0.19 (3.17%)  
 MORE ON CBM 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 CAMBREX CP (NYSE:CBM) Delayed quote dataEdit
Last Trade:5.80 USD
Trade Time:12:32AM SGT
Change:Down 0.19 (3.17%)
Prev Close:5.99
Open:6.00
Bid:N/A
Ask:N/A
1y Target Est:11.00
Day's Range:5.714 - 6.06
52wk Range:1.48 - 7.22
Volume:48,291
Avg Vol (3m):137,549
Market Cap:169.85M
P/E (ttm):13.91
EPS (ttm):0.417
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add CBM to Portfolio   Download Data

 HEADLINES 
CAMBREX CORP Financials
EDGAR Online Financials (Sat, Nov 7)
CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 5)
New Star Analyst Rankings for CAMBREX CP
StarMine (Wed, Nov 4)
Cambrex Earnings Call scheduled for 8:30 am ET today
CCBN (Wed, Nov 4)
Cambrex Reports Third Quarter 2009 Results
PR Newswire (Wed, Nov 4)
Q3 2009 Cambrex Earnings Release - After Market Close
CCBN (Tue, Nov 3)
Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
PR Newswire (Wed, Oct 28)
Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
PR Newswire (Wed, Oct 21)
Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
PR Newswire (Thu, Sep 17)
CAMBREX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Aug 25)
More Headlines for CBM...

 ANALYST 
EPS Est (next year) (Dec-09) :0.49
EPS Est (in 2 years) (Dec-10) :0.54
Avg Rec (current)*:3.0
PEG Ratio:0.81
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Cambrex Corporation, a life sciences company, provides products and services to develop and commercialize active pharmaceutical ingredients and advanced intermediates.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices